Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 23, 2023 - Issue 1
Submit an article Journal homepage
1,051
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Oligometastases in head and neck squamous cell carcinoma patients

Remco de Breea Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The NetherlandsCorrespondence[email protected]
View further author information
,
Jose A. Hardillob Department of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Rotterdam, Rotterdam, The NetherlandsView further author information
&
Mischa de Ridderc Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
Pages 1-3 | Received 27 Aug 2022, Accepted 14 Nov 2022, Published online: 18 Nov 2022

References

  • de Bree R, Senft A, Coca-Pelaz A, et al. Detection of distant metastases in head and neck cancer: changing landscape. Adv Ther. 2018 Feb;35(2):161–172.
  • Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995 Jan;13(1):8–10.
  • Vengaloor Thomas T, Packianathan S, Bhanat E, et al. Oligometastatic head and neck cancer: comprehensive review. Head Neck. 2020 Aug;42(8):2194–2201.
  • Berzenji D, Sewnaik A, Keereweer S, et al. Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma. Oral Oncol. 2021 Aug;119:105356.
  • Vincent AG, Wang W, Shokri T, et al. Treatment of oligometastatic disease in squamous cell carcinoma of the head and neck. Laryngoscope. 2021 May;131(5):E1476–80.
  • Young ER, Diakos E, Khalid-Raja M, et al. Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis. Clin Otolaryngol. 2015 Jun;40(3):208–218.
  • Schlachtenberger G, Doerr F, Menghesha H, et al. Pulmonary metastasectomy for metastatic head and neck cancer prolongs survival significantly compared to non-surgical therapy. Eur J Cardiothorac Surg. 2022 Jul 11;62(2):ezac098.
  • Wright CM, Lee DY, Shimunov D, et al. Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery. Oral Oncol. 2021 Oct;121:105509.
  • Schlachtenberger G, Doerr F, Menghesha H, et al. Patients with pulmonary metastases from head and neck cancer benefit from pulmonary metastasectomy, a systematic review. Medicina (Kaunas). 2022 Jul 27;58(8):1000.
  • Franzese C, Badalamenti M, Teriaca A, et al. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer. J Cancer Res Clin Oncol. 2021 May;147(5):1307–1313.
  • Schulz D, Wirth M, Piontek G, et al. Improved overall survival in head and neck cancer patients after specific therapy of distant metastases. Eur Arch Otorhinolaryngol. 2018 May;275(5):1239–1247.
  • Bonomo P, Greto D, Desideri I, et al. Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: is the deferral of systemic therapy a potential goal? Oral Oncol. 2019 Jun;93:1–7.
  • Bates JE, De Leo AN, Morris CG, et al. Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: single-institution outcomes. Head Neck. 2019 Jul;41(7):2309–2314.
  • Singh R, Jenkins J, Davis J, et al. A multi-institutional analysis of outcomes following stereotactic body radiation therapy for management of metastases from squamous cell carcinomas of the head and neck. J Radiosurg SBRT. 2022;8(1):11–19.
  • Olson R, Mathews L, Liu M, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial. BMC Cancer. 2020 May 5;20(1):380.
  • Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019 May 18;393(10185):2051–2058.
  • Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020 Sep 1;38(25):2830–2838.
  • Olson R, Senan S, Harrow S, et al. Quality of life outcomes after stereotactic ablative radiation Therapy (SABR) versus standard of care treatments in the oligometastatic setting: a secondary analysis of the SABR-COMET randomized trial. Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):943–947.
  • Qu XM, Chen Y, Zaric GS, et al. Is SABR cost-effective in oligometastatic cancer? An economic analysis of the SABR-COMET randomized trial. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1176–1184.
  • Kamarinos NV, Dawson LA, Saltz LB, et al. Trials of locoregional therapies inspired by SABR-COMET. Lancet. 2020 Oct 3;396(10256):956–957.
  • Moon DH, Sher DJ. Oligometastasis in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2022 Jul 4;114(4):S0360-3016(22)00660–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.